Ligand validation:2BS3

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 2BS3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2BS3_LMT_F_1257	4%	41%	0.351	0.741	1.1	1.26	2	4	9	0	100%	0.5429
2BS3_LMT_C_1257	3%	41%	0.412	0.74	1.11	1.26	2	4	7	0	100%	0.5429
2BS4_LMT_F_1257	12%	41%	0.315	0.85	1.14	1.21	2	4	8	0	100%	0.5429
2BS2_LMT_F_1257	9%	40%	0.246	0.732	1.11	1.27	2	4	9	0	100%	0.5429
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.65	0.88	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
3SZF_LMT_A_501	73%	35%	0.101	0.928	1.25	1.42	3	5	2	0	100%	1
3T14_LMT_A_501	72%	33%	0.12	0.945	1.22	1.51	3	10	2	0	100%	1
3T2Y_LMT_A_501	70%	32%	0.13	0.948	1.27	1.52	3	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.